the association between autophagy and ovarian cancer
Clicks: 103
ID: 136296
2012
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
103 views
26 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #57 of 73 articles by views in journal of veterinary research
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Ovarian cancer is the most common cause of cancer death in all gynecological cancers. The mortality of this cancer is high due to the fact that the symptoms of this disease does not occur until its advanced stage. Surgery, chemotherapy and radiation therapy are current cancer therapies for ovarian cancer. However the recent studies reported that autophagy also can be a novel therapeutic strategy for this cancer. Autophagy leads to cell death when it is activated excessively in the cell and so it can be used for the treatment of neoplastic or chemoresistant ovarian cancer cells. In this review, in order to understand the association between autophagy
and ovarian cancer, we summarized the general characteristics of ovarian cancer, autophagy and the relationship between these two concepts.
| Reference Key |
demirezen2012gormthe
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Şayeste Demirezen;Merve Özcan;Sinan Beksaç |
| Journal | journal of veterinary research |
| Year | 2012 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.